A Breast Cancer Surgeon Who Keeps Challenging the Status Quo
UCSF Breastcare Surgery - September 30, 2015
The NY Times profiled UCSF breast cancer surgeon Dr. Laura Esserman and her challenge to the conventional wisdom surrounding breast cancer screening. Esserman argues that most patients will not benefit from early detection of ductal carcinoma in situ (DCIS) lesions and further that the ominous word "carcinoma" be dropped from the medical term and the condition renamed "indolent lesions of epithelial origin," or IDLEs.
Late one afternoon this summer, Dr. Laura J. Esserman, a breast cancer surgeon at the University of California, San Francisco, sat in a darkened room scrutinizing a [...]